-
Boehringer Ingelheim initiates Phase II study of BI 1815368, a potential first-in-class oral treatment for diabetic macular edema
07 Jul 2025 11:00 GMT
… and progressive.10 About Boehringer Ingelheim Boehringer Ingelheim is a biopharmaceutical company … . Our approximately 54,500 employees serve over 130 markets … Learn more at www.boehringer-ingelheim.com. Boehringer Ingelheim’s Intended Audiences Notice …
-
Healthy.io, Geisinger and Boehringer Ingelheim Study Reveals Significant Increase in Albuminuria Identification with the Addition of Smartphone Technology
20 Jun 2025 14:09 GMT
… research studies. With 26,000 employees, including 1,700 employed physicians … Instagram, LinkedIn and X.
About Boehringer Ingelheim
Boehringer Ingelheim is a biopharmaceutical company active … chain. Our approximately 54,500 employees serve over 130 markets to …
-
Boehringer Ingelheim Launches Next Generation Innovative Three-in-One Poultry Vaccine in India
18 Jun 2025 07:01 GMT
… the hatchery.
Boehringer Ingelheim Animal Health
Boehringer Ingelheim provides innovation for … www.boehringer-ingelheim.com/animal-health.
About Boehringer Ingelheim
Boehringer Ingelheim is … More than 53,500 employees serve over 130 markets …
-
Boehringer Ingelheim and Eko Health Inc. enter digital health collaboration to improve heart murmur detection in dogs
10 Jun 2025 10:00 GMT
… they deserve.
About Boehringer Ingelheim
Boehringer Ingelheim is a biopharmaceutical company … More than 53,500 employees serve over 130 markets … at boehringer-ingelheim.com.
About Boehringer Ingelheim – Animal Health business
Boehringer Ingelheim provides …
-
Echosens and Boehringer Ingelheim Expand Long-Standing Collaboration to Accelerate Progress in MASH Diagnosis and Care
10 Jun 2025 01:25 GMT
… non-invasive liver diagnostics, and Boehringer Ingelheim, a global biopharmaceutical company, … www.echosens.com/
About Boehringer Ingelheim
Boehringer Ingelheim is a biopharmaceutical company active … . More than 54,500 employees serve over 130 markets to …
-
OSE Immunotherapeutics Announces that its Partner Boehringer Ingelheim Will Present Early Clinical Evidence of Innate Immune Modulation and Anti-Tumor Activity via SIRPα Blockade in Two Ongoing Trials at ASCO 2025
23 May 2025 05:00 GMT
… Medicine, Therapy Area Oncology at Boehringer Ingelheim. “Boehringer is developing various … – 11:15am – 12:45pm CDT Boehringer Ingelheim Boehringer Ingelheim is a biopharmaceutical company active … chain. More than 54,400 employees serve over 130 markets to …
-
Boehringer Ingelheim Showcases Bold Vision For The Future Of Cancer Care At ASCO 2025
22 May 2025 23:03 GMT
… Presentations at ASCO 2025 from Boehringer Ingelheim's innovative pipeline highlight … today and for generations.
About Boehringer Ingelheim
Boehringer Ingelheim is a biopharmaceutical company active … . More than 53,500 employees serve over 130 markets to …
-
Boehringer Ingelheim to present early clinical evidence of innate immune modulation and anti-tumor activity via SIRPα blockade in two ongoing trials at ASCO 2025
22 May 2025 21:05 GMT
… Medicine, Therapy Area Oncology at Boehringer Ingelheim. “Boehringer is developing various … – 11:15am – 12:45pm CDT
Boehringer Ingelheim
Boehringer Ingelheim is a biopharmaceutical company active … chain. More than 54,500 employees serve over 130 markets to …
-
OMD Expands Boehringer Ingelheim Remit
12 May 2025 18:44 GMT
Global pharmaceutical giant Boehringer Ingelheim has signed a new five- … .
While OMD leads the account, Boehringer Ingelheim will also utilize other Omnicom … and now has 54,500 employees worldwide. Brands include Frontline, Jardiance …
-
Boehringer Ingelheim starts Phase II study of its potential first-in-class oral compound as a treatment for Geographic Atropy
06 May 2025 12:00 GMT
… fear and anxiety. 5
About Boehringer Ingelheim
Boehringer Ingelheim is a biopharmaceutical company active … . More than 54,500 employees serve over 130 markets to … Learn more at www.boehringer-ingelheim.com
Boehringer Ingelheim’s Intended Audiences Notice
…
About
© 1995-2025